Confirming the functional importance of a protein-DNA interaction

Cold Spring Harbor Protocols

Volumn 7, Issue 7, 2012, Pages 733-757

  Carey, Michael F ^a   Peterson, Craig L ^a   Smale, Stephen T ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; DNA BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; DNA;

AFFINITY CHROMATOGRAPHY; ARTICLE; BINDING AFFINITY; CHROMATIN IMMUNOPRECIPITATION; CROSS LINKING; DNA SEQUENCE; GEL MOBILITY SHIFT ASSAY; GENE DISRUPTION; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; LOSS OF FUNCTION MUTATION; MASS SPECTROMETRY; MICROARRAY ANALYSIS; NONHUMAN; PROTEIN BINDING; PROTEIN DNA INTERACTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSCRIPTION REGULATION; METABOLISM; METHODOLOGY; MOLECULAR BIOLOGY;

DNA; DNA-BINDING PROTEINS; MOLECULAR BIOLOGY; PROTEIN BINDING;

EID: 84864428085     PISSN: 19403402     EISSN: 15596095     Source Type: Journal    
DOI: 10.1101/pdb.top070060     Document Type: Article

References (91)

1. Amarzguioui M, Lundberg P, Cantin E, Hagstrom J, Behlke MA, Rossi JJ. 2006. Rational design and in vitro and in vivo delivery of Dicer substrate siRNA. Nat Protoc 1: 508-517.
2. Anderson E, Boese Q, Khvorova A, Karpilow J. 2008. Identifying siRNA induced off-targets by microarray analysis. Methods Mol Biol 442: 45-63.
3. Barton GM, Medzhitov R. 2002. Retroviral delivery of small interfering RNA into primary cells. Proc Natl Acad Sci 99: 14943-14945.
4. Beima KM, Miazgowicz MM, Lewis MD, Yan PS, Huang TH, Weinmann AS. 2006. T-bet binding to newly identified target gene promoters is cell type-independent but results in variable context-dependent functional effects. J Biol Chem 281: 11992-12000.
5. Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H. 1990. The protein Id: A negative regulator of helix-loop-helix binding proteins. Cell 61: 49-59.
6. Boyd KE, Farnham PJ. 1997. Myc versus USF: Discrimination at the cad gene is determined by core promoter elements. Mol Cell Biol 17: 2529-2537.
7. Boyd KE, Wells J, Gutman J, Bartley SM, Farnham PJ. 1998. c-Myc target gene specificity is determined by a post-DNA-binding mechanism. Proc Natl Acad Sci 95: 13887-13892.
8. Bradley MN, Zhou L, Smale ST. 2003. C/EBPb regulation in lipo-poly-sac-charide-stimulated macrophages. Mol Cell Biol 23: 4841-4858.
9. Branch AD. 1998. A good antisense molecule is hard to find. Trends Biochem Sci 23: 45-50.
10. Braunstein M, Rose AB, Holmes SG, Allis CD, Broach JR. 1993. Transcriptional silencing in yeast is associated with reduced nucleosome acety-lation. Genes Dev 7: 592-604.
11. Brummelkamp TR, Bernards R, Agami R. 2002. A system for stable expression of short interfering RNAs in mammalian cells. Science 296: 550-553.
12. Capecchi MR. 1989. Altering the genome by homologous recombination. Science 244: 1288-1292.
13. Capecchi MR. 2005. Gene targeting in mice: Functional analysis of the mammalian genome for the twenty-first century. Nat Rev Genet 6: 507-512.
14. Clevers HC, Grosschedl R. 1996. Transcriptional control of lymphoid development: Lessons from gene targeting. Immunol Today 17: 336-343.
15. Cullen BR. 2006. Enhancing and confirming the specificity of RNAi experiments. Nat Methods 3: 677-681.
16. Descombes P, Schibler U. 1991. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 67: 569-579.
17. Dong J, Jimi E, Zhong H, Hayden MS, Ghosh S. 2008. Repression of gene expression by unphosphorylated NF-B p65 through epigenetic mechanisms. Genes Dev 22: 1159-1173.
18. Dynan WS, Tjian R. 1983a. Isolation of transcription factors that discrim- inate between different promoters recognized by RNA polymerase II. Cell 32: 669-680.
19. Dynan WS, Tjian R. 1983b. The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter. Cell 35: 79-87.
20. Eisenbeis CF, Singh H, Storb U. 1995. Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. Genes Dev 9: 1377-1387.
21. Elbashir SM, Lendeckel W, Tuschl T. 2001a. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 15: 188-200.
22. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. 2001b. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411: 494-498.
23. Elbashir SM, Harborth J, Weber K, Tuschl T. 2002. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26: 199-213.
24. Ernst P, Hahm K, Smale ST. 1993. Both LyF-1 and an Ets protein interact with a critical promoter element in the murine terminal transferase gene. Mol Cell Biol 13: 2982-2992.
25. Ernst P, Hahm K, Trinh L, Davis JN, Roussel MF, Turck CW, Smale ST. 1996. A potential role for Elf-1 in terminal transferase gene regulation. Mol Cell Biol 16: 6121-6131.
26. Fiering S, Northrop JP, Nolan GP, Mattila PS, Crabtree GR, Herzenberg LA. 1990. Single cell assay of a transcription factor reveals a threshold in transcription activated by signals emanating from the T-cell antigen receptor. Genes Dev 4: 1823-1834.
27. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. 1998. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391: 806-811.
28. Folger K, Thomas K, Capecchi MR. 1984. Analysis of homologous recom- bination in cultured mammalian cells. Cold Spring Harbor Symp Quant Biol 49: 123-138.
29. Georgopoulos K, Moore DD, Derfler B. 1992. Ikaros, an early lymphoid- specific transcription factor and a putative mediator for T cell commitment. Science 258: 808-812.
30. Gillemans N, Tewari R, Lindeboom F, Rottier R, de Wit T, Wijgerde M, Grosveld F, Philipsen S. 1998. Altered DNA-binding specificity mutants of EKLF and Sp1 show that EKLF is an activator of the -globin locus control region in vivo. Genes Dev 12: 2863-2873.
31. Gilmour DS, Lis JT. 1984. Detecting protein-DNA interactions in vivo: Distribution of RNA polymerase on specific bacterial genes. Proc Natl Acad Sci 81: 4275-4279.
32. Gilmour DS, Lis JT. 1985. In vivo interactions of RNA polymerase II with genes of Drosophila melanogaster. Mol Cell Biol 5: 2009-2018.
33. Gilmour DS, Lis JT. 1986. RNA polymerase II interacts with the promoter region of the noninduced hsp70 gene in Drosophila melanogaster cells. Mol Cell Biol 6: 3984-3989.
34. Gu H, Marth JD, Orban PC, Mossmann H, Rajewsky K. 1994. Deletion of a DNA polymerase B gene segment in T cells using cell type-specific gene targeting. Science 265: 103-106.
35. Hahm K, Ernst P, Lo K, Kim GS, Turck C, Smale ST. 1994. The lymphoid transcription factor LyF-1 is encoded by specific, alternatively-spliced mRNAs derived from the Ikaros gene. Mol Cell Biol 14: 7111-7123.
36. He L, Hannon GJ. 2004. MicroRNSa: Small RNAs with a big role in generegulation. Nat Rev Genet 5: 522-531.
37. Hecht A, Grunstein M. 1999. Mapping DNA interaction sites of chromo- somal proteins using immunoprecipitation and polymerase chain reaction. Methods Enzymol 304: 399-414.
38. Hecht A, Strahl-Bolsinger S, Grunstein M. 1996. Spreading of transcription- al repressor SIR3 from telomeric heterochromatin. Nature 383: 92-96.
39. Hollenhorst PC, Jones DA, Graves BJ. 2004. Expression profiles frame the promoter specificity dilemma of the ETS family of transcription factors. Nucleic Acids Res 32: 5693-5702.
40. Hollenhorst PC, Shah AA, Hopkins C, Graves BJ. 2007. Genome-wide analyses reveal properties of redundant and specific promoter occupancy within the ETS gene family. Genes Dev 21: 1882-1894.
41. Jonsen MD, Petersen JM, Xu QP, Graves BJ. 1996. Characterization of the cooperative function of inhibitory sequences in Ets-1. Mol Cell Biol 16: 2065-2073.
42. Kadonaga JT, Carner KR, Masiarz FR, Tjian R. 1987. Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell 51: 1079-1090.
43. Kim TK, Maniatis M. 1997. The mechanism of transcriptional synergy of an in vitro assembled interferon- enhanceosome. Mol Cell 1: 119-129.
44. Kim DH, Rossi JJ. 2007. Strategies for silencing human disease using RNA interference. Nat Rev Genet 8: 173-184.
45. Krylov D, Kasai K, Echlin DR, Taparowsky EJ, Arnheiter H, Vinson C. 1997. A general method to design dominant negatives to B-HLHZip proteins that abolish DNA binding. Proc Natl Acad Sci 94: 12274-12279.
46. Langlands K, Yin X, Anand G, Prochownik EV. 1997. Differential interactions of Id proteins with basic helix-loop-helix transcription factors. J Biol Chem 272: 19785-19793.
47. Lassus P, Rodriguez J, Lazebnik Y. 2002. Confirming specificity of RNAi in mammalian cells. Sci STKE 147: PL13.
48. Lauring J, Schlissel MS. 1999. Distinct factors regulate the murine RAG-2 promoter in B and T cell lines. Mol Cell Biol 19: 2601-2612.
49. Lee GM, Donaldson LW, Pufall MA, Kang HS, Pot I, Graves BJ, McIntosh LP. 2005. The structural and dynamic basis of Ets-1 DNA binding autoinhibition. J Biol Chem 280: 7088-7099.
50. Lefstin JA, Yamamoto KR. 1998. Allosteric effects of DNA on transcriptional regulators. Nature 392: 885-888.
51. Lehman AM, Ellwood KB, Middleton BE, Carey M. 1998. Compensatory energetic relationships between upstream activators and the RNA polymerase II general transcription machinery. J Biol Chem 273: 932-939.
52. Li Q, Johnston SA. 2001. Are all DNA binding and transcription regulation by an activator physiologically relevant? Mol Cell Biol 21: 2467-2474.
53. Lipston KE, Baserga R. 1989. Transcriptional activity of the human thyme-dine kinase gene determined by a method using the polymerase chain reaction and an intron-specific probe. Proc Natl Acad Sci 86: 9774-9777.
54. Lo K, Landau NR, Smale ST. 1991. LyF-1, a transcriptional regulator that interacts with a novel class of promoters for lymphocyte-specific genes. Mol Cell Biol 11: 5229-5243.
55. Lodish H, Baltimore D, Berk A, Zipursky SL, Darnell J. 1996. Molecular cell biology, 3rd ed. W.H. Freeman, New York.
56. Martone R, Euskirchen G, Bertone P, Hartman S, Royce TE, Luscombe NM, Rinn JL, Nelson FK, Miller P, Gerstein M, et al. 2003. Distribution of NF-B-binding sites across human chromosome 22. Proc Natl Acad Sci 100: 12247-12252.
57. Mauxion F, Jamieson C, Yoshida M, Arai K, Sen R. 1991. Comparison of constitutive and inducible transcriptional enhancement mediated by B-related sequences: Modulation of activity in B cells by human T-cell leukemia virus type I tax gene. Proc Natl Acad Sci 88: 2141-2145.
58. ′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nat Biotechnol 20: 497-500.
59. Okamura RM, Sigvardsson M, Galceran J, Verbeek S, Clevers H, Grosschedl R. 1998. Redundant regulation of T cell differentiation and TCR gene expression by the transcription factors LEF-1 and TCF-1. Immu- nity 8: 11-20.
60. Olive M, Williams SC, Dezan C, Johnson PF, Vinson C. 1996. Design of a C/ EBP-specific, dominant-negative bZIP protein with both inhibitory and gain-of-function properties. J Biol Chem 271: 2040-2047.
61. Orlando V, Paro R. 1993. Mapping Polycomb-repressed domains in the bithorax complex using in vivo formaldehyde cross-linked chromatin. Cell 75: 1187-1198.
62. Orlando V, Strutt H, Paro R. 1997. Analysis of chromatin structure by in vivo formaldehyde cross-linking. Methods 11: 205-214.
63. Paddison PJ. 2008. RNA interference in mammalian cell systems. Curr Top Microbiol Immunol 320: 1-19.
64. Paddison PJ, Caudy AA, Bernstein E, Hannon GJ, Conklin DS. 2002. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev 16: 948-958.
65. Panne D, Maniatis T, Harrison SC. 2007. An atomic model of the interferon- enhanceosome. Cell 129: 1111-1123.
66. Parekh BS, Maniatis T. 1999. Virus infection leads to localized hyperacety- lation of histones H3 and H4 at the IFN- promoter. Mol Cell 3: 125-129.
67. Paul CP, Good PD, Winer I, Engelke DR. 2002. Effective expression of small interfering RNA in human cells. Nat Biotechnol 20: 505-508.
68. Pei Y, Tuschl T. 2006. On the art of identifying effective and specific siRNAs. Nat Methods 3: 670-676.
69. Phuc Le P, Friedman JR, Schug J, Brestelli JE, Parker JB, Bochkis IM, Kaest-ner KH. 2005. Glucocorticoid receptor-dependent gene regulatory networks. PLoS Genet 1: e16.
70. Plevy SE, Gemberling J, Hsu S, Dorner AJ, Smale ST. 1997. Multiple control elements mediate activation of the murine and human IL-12 p40 promoters: Evidence of functional synergy between C/EBP and Rel pro- teins. Mol Cell Biol 17: 4572-4588.
71. ′ enhancer activity. Mol Cell Biol 12: 368-378.
72. Pufall MA, Lee GM, Nelson ML, Kang HS, Velyvis A, Kay LE, McIntosh LP, Graves BJ. 2005. Variable control of Ets-1 DNA binding by multiple phosphates in an unstructured region. Science 309: 142-145.
73. Reddy ST, Gilbert RS, Xie W, Luner S, Herschman HR. 1994. TGF- inhibits both endotoxin-induced prostaglandin synthesis and expression of the TIS10/prostaglandin synthase 2 gene in murine macrophag- es. J Leukoc Biol 55: 192-200.
74. Rishi V, Vinson C. 2003. Dominant-negative mutants of helix-loop-helix proteins: Transcriptional inhibition. Methods Enzymol 370: 454-466.
75. Rundlett SE, Carmen AA, Suka N, Turner BM, Grunstein M. 1998. Tran- scriptional repression by UME6 involves deacetylation of lysine 5 of histone H4 by RPD3. Nature 392: 831-835.
76. Sen GL, Blau HM. 2006. A brief history of RNAi: The silence of the genes. FASEB J 20: 1293-1299.
77. Shah PC, Bertolino E, Singh H. 1997. Using altered specificity Oct-1 and Oct-2 mutants to analyze the regulation of immunoglobulin gene transcription. EMBO J 16: 7105-7117.
78. Smithies O, Gregg RG, Boggs SS, Koralewski MA, Kucherlapati RS. 1985. Insertion of DNA sequences into the human chromosomal -globin locus by homologous recombination. Nature 317: 230-234.
79. Snøve O Jr, Rossi JJ. 2006. Expressing short hairpin RNAs in vivo. Nat Methods 3: 689-695.
80. Solomon MJ, Varshavsky A. 1985. Formaldehyde-mediated DNA-protein crosslinking: A probe for in vivo chromatin structures. Proc Natl Acad Sci 82: 6470-6474.
81. Solomon MJ, Larsen PL, Varshavsky A. 1988. Mapping protein-DNA inter- actions in vivo with formaldehyde: Evidence that histone H4 is retained on a highly transcribed gene. Cell 53: 937-947.
82. Stein CA. 1998. How to design an antisense oligodeoxynucleotide experi- ment: A consensus approach. Antisense Nucleic Acid Drug Dev 8: 129-132.
83. Svoboda P. 2007. Off-targeting and other non-specific effects of RNAi ex- periments in mammalian cells. Curr Opin Mol Ther 9: 248-257.
84. Thanos D, Maniatis T. 1995a. Virus induction of human IFN gene-expression requires the assembly of an enhanceosome. Cell 83: 1091-1100.
85. Thanos D, Maniatis T. 1995b. NF-B: A lesson in family values. Cell 80: 529-532.
86. Thomas KR, Capecchi MR. 1987. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51: 503-512.
87. van Genderen C, Okamura RM, Farinas I, Quo RG, Parslow TG, Bruhn L, Grosschedl R. 1994. Development of several organs that require induc- tive epithelial-mesenchymal interactions is impaired in LEF-1-deficient mice. Genes Dev 8: 2691-2703.
88. Verbeek S, Izon D, Hofhuis F, Robanus-Maandag E, te Riele H, van de Wetering M, Oosterwegel M, Wilson A, MacDonald HR, Clevers H. 1995. An HMG-box-containing T-cell factor required for thymocyte differentiation. Nature 374: 70-74.
89. Walter J, Dever CA, Biggin MD. 1994. Two homeo domain proteins bind with similar specificity to a wide range of DNA sites in Drosophila embryos. Genes Dev 8: 1678-1692.
90. Wathelet MG, Lin CH, Parekh BS, Ronco LV, Howley PM, Maniatis T. 1998. Virus infection induces the assembly of coordinately activated transcription factors on the IFN- enhancer in vivo. Mol Cell 1: 507-518.
91. Wiznerowicz M, Szulc J, Trono D. 2006. Tuning silence: Conditional systems for RNA interference. Nat Methods 3: 682-688.